Spain

Krka Farmacéutica has been present in Spain since 2011. Marketing started in 2012 with the promotion of three different medicines: Nolpaza (Pantoprazole Krka), Atoris (Atorvastatin Krka) and Clopidogrel Krka. Today we have a 100 INN (international non-proprietary name) portfolio and over 350 SKUs (stock keeping units).

We successfully focus on generic medicines for cardiovascular, gastrointestinal and CNS diseases. In 2019, we launched the first over-the-counter (OTC) medicine Herbion, which was followed since then by another 4 different successful brands within the Cough&Cold, Pain and Gastro categories; building up our non-prescription portfolio to today’s status.

Our promotion focuses in specific medical specialties as well as retail and hospital pharmacies, providing a wide range of branded and INN medicines that contribute to our essential mission: living a healthy live.